We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

Clesrovimab (MK-1654), an Investigational RSV Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and ...

We recently compiled a list of the 7 Blue Chip Stocks with Low PE Ratios. In this article, we are going to take a look at ...

While you may think of healthcare as only covering human health, animal and pet health is also a growing sector. Click to read.

Report on how AI is redefining market landscape - The Global Biopolymers Market size is estimated to grow by USD 17.11 ...

Garijo sat down with Bloomberg to discuss her growth obsession, navigating geopolitical risk, the benefits of diversity and ...

Kineta has completed enrollment in the monotherapy cohorts of the Phase 1 VISTA-101 clinical trial. The ongoing Phase 1 study is now enrolling patients into cohorts evaluating KVA12123 in combination ...

Kineta, Inc. (OTC Pink: KANT) , a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that its ...

This week marked the start of the third-quarter earnings season, with Johnson & Johnson exceeding Wall Street’s expectations.

There are huge stakes for health care in the upcoming U.S. election — and leaders from across the political spectrum weighed in on policy ...

Johnson & Johnson’s portfolio now includes treatment options for patients with rheumatoid arthritis, axial spondylarthritis, and polyarticular juvenile idiopathic arthritis.High Wycombe, UK, 17 ...

Scaffold Technology MarketThe global scaffold technology market is estimated to be valued at USD 1,490.7 million in 2024, marking the beginning of a transformative era fueled by consumer-centric ...